Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.8251
-0.1949 (-19.11%)
At close: May 13, 2025, 4:00 PM
0.8399
+0.0148 (1.79%)
Pre-market: May 14, 2025, 8:44 AM EDT

Coherus BioSciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
82.41125.99102.8963.55417.2541.16
Upgrade
Short-Term Investments
--14.86128.13--
Upgrade
Cash & Short-Term Investments
82.41125.99117.75191.68417.2541.16
Upgrade
Cash Growth
-68.28%7.00%-38.57%-54.05%-22.91%204.59%
Upgrade
Accounts Receivable
60.49111.32260.52109.96123.02157.05
Upgrade
Other Receivables
1.9511.01----
Upgrade
Receivables
62.44122.33260.52109.96123.02157.05
Upgrade
Inventory
3.5270.0962.6138.7937.6444.23
Upgrade
Prepaid Expenses
-23.1734.7640.824.4625.04
Upgrade
Other Current Assets
138.97-----
Upgrade
Total Current Assets
287.34341.58475.63381.23602.32767.48
Upgrade
Property, Plant & Equipment
-7.3611.0314.4416.0110.11
Upgrade
Goodwill
--0.940.940.90.94
Upgrade
Other Intangible Assets
52.9853.6570.734.992.662.62
Upgrade
Other Long-Term Assets
30.7545.9571.2779.2457.4460.5
Upgrade
Total Assets
371.07448.53629.6480.85679.33841.65
Upgrade
Accounts Payable
-28.4635.2211.5316.1615.2
Upgrade
Accrued Expenses
147.74227.04291.11122.85145.68127.32
Upgrade
Current Portion of Long-Term Debt
-1.15----
Upgrade
Current Portion of Leases
-1.692.154.323.493.13
Upgrade
Other Current Liabilities
0.1324.653.3---
Upgrade
Total Current Liabilities
147.87282.98331.77138.69165.33145.65
Upgrade
Long-Term Debt
265.35292.52473.37471.06408.28404.02
Upgrade
Long-Term Leases
-3.295.335.057.259.95
Upgrade
Long-Term Deferred Tax Liabilities
-1.11.1---
Upgrade
Other Long-Term Liabilities
141.320.6311.463.470.751.05
Upgrade
Total Liabilities
554.54580.52823.03618.27581.61560.68
Upgrade
Common Stock
-183.470.010.010.010.010.01
Upgrade
Additional Paid-In Capital
-1,4191,3861,2041,1481,044
Upgrade
Retained Earnings
--1,551-1,580-1,342-1,050-762.75
Upgrade
Comprehensive Income & Other
--0.28-0.25-0.25-0.27-0.27
Upgrade
Total Common Equity
-183.47-131.99-193.43-137.4297.73280.97
Upgrade
Shareholders' Equity
-183.47-131.99-193.43-137.4297.73280.97
Upgrade
Total Liabilities & Equity
371.07448.53629.6480.85679.33841.65
Upgrade
Total Debt
265.35298.65480.84480.42419.02417.1
Upgrade
Net Cash (Debt)
-182.94-172.66-363.09-288.74-1.83124.06
Upgrade
Net Cash Per Share
-1.59-1.50-3.86-3.72-0.021.49
Upgrade
Filing Date Shares Outstanding
115.86115.9112.7179.6177.2872.79
Upgrade
Total Common Shares Outstanding
115.86115.61112.2278.8576.9372.51
Upgrade
Working Capital
139.4758.6143.86242.54437621.83
Upgrade
Book Value Per Share
-1.58-1.14-1.72-1.741.273.87
Upgrade
Tangible Book Value
-236.45-185.64-265.1-143.3594.16277.41
Upgrade
Tangible Book Value Per Share
-2.04-1.61-2.36-1.821.223.83
Upgrade
Machinery
-18.0717.7317.3916.0418.57
Upgrade
Construction In Progress
---0.70.390.31
Upgrade
Leasehold Improvements
-5.755.756.25.945.83
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q